Home NDC 71335-1013 Acyclovir
Product NDC 71335-1013
11-digit product format 713351013
Labeler code 71335
Product ID 71335-1013_1dc4a821-b0d6-433c-94f4-61c1a479102a
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Acyclovir
Dosage form CAPSULE
Route ORAL
Labeler Bryant Ranch Prepack
Application ANDA201445
Marketing category ANDA
Marketing start 2016-10-15
Marketing end 0000-00-00
Substance ACYCLOVIR
Active strength 200 mg/1
Pharmacologic classes DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# NDC, Effective, Action table NDC Effective Action Document Indexing SPL Related label 71335-1013-0 2024-01-30 C162847 48780-1 1030e365-14fd-111a-e063-dadaa90a10e2 Acyclovir Capsules, USP 200 mg Nivagen Pharmaceuticals, Inc. 71335-1013-1 2024-01-30 C162847 48780-1 1030e365-14fd-111a-e063-dadaa90a10e2 Acyclovir Capsules, USP 200 mg Nivagen Pharmaceuticals, Inc. 71335-1013-2 2024-01-30 C162847 48780-1 1030e365-14fd-111a-e063-dadaa90a10e2 Acyclovir Capsules, USP 200 mg Nivagen Pharmaceuticals, Inc. 71335-1013-3 2024-01-30 C162847 48780-1 1030e365-14fd-111a-e063-dadaa90a10e2 Acyclovir Capsules, USP 200 mg Nivagen Pharmaceuticals, Inc. 71335-1013-4 2024-01-30 C162847 48780-1 1030e365-14fd-111a-e063-dadaa90a10e2 Acyclovir Capsules, USP 200 mg Nivagen Pharmaceuticals, Inc. 71335-1013-5 2024-01-30 C162847 48780-1 1030e365-14fd-111a-e063-dadaa90a10e2 Acyclovir Capsules, USP 200 mg Nivagen Pharmaceuticals, Inc. 71335-1013-6 2024-01-30 C162847 48780-1 1030e365-14fd-111a-e063-dadaa90a10e2 Acyclovir Capsules, USP 200 mg Nivagen Pharmaceuticals, Inc. 71335-1013-7 2024-01-30 C162847 48780-1 1030e365-14fd-111a-e063-dadaa90a10e2 Acyclovir Capsules, USP 200 mg Nivagen Pharmaceuticals, Inc. 71335-1013-8 2024-01-30 C162847 48780-1 1030e365-14fd-111a-e063-dadaa90a10e2 Acyclovir Capsules, USP 200 mg Nivagen Pharmaceuticals, Inc. 71335-1013-9 2024-01-30 C162847 48780-1 1030e365-14fd-111a-e063-dadaa90a10e2 Acyclovir Capsules, USP 200 mg Nivagen Pharmaceuticals, Inc.
DailyMed Package Descriptions# DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 71335-1013 ACYCLOVIR CAPSULE [BRYANT RANCH PREPACK] 4 Legacy NDC, 10 package rows 20220316_1dc4a821-b0d6-433c-94f4-61c1a479102a.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 71335-1013-0 71335101300 90 CAPSULE in 1 BOTTLE (71335-1013-0) 90 capsule 2022-03-09 0000-00-00 No No Current 71335-1013-1 71335101301 30 CAPSULE in 1 BOTTLE (71335-1013-1) 30 capsule 2020-04-07 0000-00-00 No No Current 71335-1013-2 71335101302 25 CAPSULE in 1 BOTTLE (71335-1013-2) 25 capsule 2018-11-21 0000-00-00 No No Current 71335-1013-3 71335101303 35 CAPSULE in 1 BOTTLE (71335-1013-3) 35 capsule 2022-03-09 0000-00-00 No No Current 71335-1013-4 71335101304 50 CAPSULE in 1 BOTTLE (71335-1013-4) 50 capsule 2020-03-05 0000-00-00 No No Current 71335-1013-5 71335101305 100 CAPSULE in 1 BOTTLE (71335-1013-5) 100 capsule 2022-03-09 0000-00-00 No No Current 71335-1013-6 71335101306 40 CAPSULE in 1 BOTTLE (71335-1013-6) 40 capsule 2020-05-26 0000-00-00 No No Current 71335-1013-7 71335101307 60 CAPSULE in 1 BOTTLE (71335-1013-7) 60 capsule 2019-01-04 0000-00-00 No No Current 71335-1013-8 71335101308 120 CAPSULE in 1 BOTTLE (71335-1013-8) 120 capsule 2022-03-09 0000-00-00 No No Current 71335-1013-9 71335101309 20 CAPSULE in 1 BOTTLE (71335-1013-9) 20 capsule 2022-03-09 0000-00-00 No No Current